Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page
- ChecktodayChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has been updated to reflect new dates, specifically the addition of '2025-04-22' and '2025-04-21', while removing older dates such as '2025-03-18' and '2025-03-17'.SummaryDifference1%
- Check22 days agoChange DetectedThe webpage has been updated to include new identifiers and collaborators related to a clinical trial for metastatic lung cancer, while significant details about the trial's objectives and treatment methods have been removed.SummaryDifference38%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.SummaryDifference0.2%
- Check51 days agoChange DetectedThe webpage has updated its date references, removing several past dates and adding new future dates, indicating a shift in the timeline of events or updates.SummaryDifference0.7%
Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.